Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides.
Autor: | Dungan, Lara, Dunne, Jean, Savio, Michael, Kalaszi, Marianna, McElheron, Matt, Lynagh, Yvonne, O'Driscoll, Kate, Roche, Carmel, Qureshi, Ammara, Crowley, Brendan, Conlon, Niall, Kearney, Hugh |
---|---|
Zdroj: | Neurology® Neuroimmunology & Neuroinflammation; May2024, Vol. 11 Issue 3, p1-11, 11p |
Databáze: | Complementary Index |
Externí odkaz: |